In breast cancer, it seems that heterozygous BRCA1-mutated microenvironment in germline BRCA1 mutation carriers may significantly contribute to breast cancer development by creating a pro-tumorigenic niche [66]. The gene discussed is BRCA1; the disease is breast cancer.